Abstract:Particulate matter (PM)-induced cardiometabolic disorder contributes to the progression of cardiac diseases, but its epigenetic mechanisms are largely unknown. This study used bioinformatic analysis, in vivo and in vitro multiple models to investigate the role of PM-induced cardiac fibroblast growth factor 1 (FGFR1) methylation and its impact on cardiomyocyte lipid metabolic disruption. Bioinformatic analysis revealed that FGFR1 was associated with cardiac pathologies, mitochondrial function and metabolism, supporting the possibility that FGFR1 may play regulatory roles in PM-induced cardiac functional impairment and lipid metabolism disorders. Individually ventilated cage (IVC)-based real-ambient PM exposure system mouse models were used to expose C57/BL6 mice for six and fifteen weeks. The results showed that PM induced cardiac lipid metabolism disorder, DNA nucleotide methyltransferases (DNMTs) alterations and FGFR1 expression declines in mouse heart. Lipidomics analysis revealed that carnitines, phosphoglycerides and lysophosphoglycerides were most significantly affected by PM exposure. At the cellular level, AC16 cells treated with FGFR1 inhibitor (PD173074) led to impaired mitochondrial and metabolic functions in cardiomyocytes. Inhibition of DNA methylation in cells by 5-AZA partially restored the FGFR1 expression, ameliorated cardiomyocyte injury and mitochondrial functions. These changes involved alterations in AMP-activated protein kinase (AMPK)-peroxisome proliferator activated receptors gamma, coactivator 1 alpha (PGC1α) pathways. Bisulfite sequencing PCR (BSP) and DNA methylation specific PCR (MSP) confirmed that PM exposure induced FGFR1 gene promoter region methylation. These results suggested that, by inducing FGFR1 methylation, PM exposure would affect cardiac injury and deranged lipid metabolism. Overexpression of FGFR1 in mouse heart using adeno-associated virus 9 (AAV9) effectively alleviated PM-induced cardiac impairment and metabolic disorder. Our findings identified that FGFR1 methylation might be one of the potential indicators for PM-induced cardiac mitochondrial and metabolic dysfunction, providing novel insights into underlying PM-related cardiotoxic mechanisms.

PM2.5-induced Extensive DNA Methylation Changes in the Heart of Zebrafish Embryos and the Protective Effect of Folic Acid.

Protective effects of folic acid on PM2.5-induced cardiac developmental toxicity in zebrafish embryos by targeting AhR and Wnt/β-catenin signal pathways.

Synergistic Protective Effects of Folic Acid and Resveratrol Against Fine Particulate Matter-Induced Heart Malformations in Zebrafish Embryos.

AHR-mediated M6a RNA Methylation Contributes to PM2.5-induced Cardiac Malformations in Zebrafish Larvae.

Using Immunofluorescence to Detect PM2.5-induced DNA Damage in Zebrafish Embryo Hearts

AHR-mediated ROS Production Contributes to the Cardiac Developmental Toxicity of PM2.5 in Zebrafish Embryos.

PM2.5 Induces Heart Defects Via AHR/ROS-Mediated Endoplasmic Reticulum Stress

Fine Particulate Matter Induces Heart Defects Via AHR/ROS-mediated Endoplasmic Reticulum Stress.

Evaluation of Cardiovascular Toxicity of Folic Acid and 6S-5-methyltetrahydrofolate-calcium in Early Embryonic Development

Crosstalk between AhR and wnt/β-catenin signal pathways in the cardiac developmental toxicity of PM2.5 in zebrafish embryos.

PM2.5 induces mitochondrial dysfunction via AHR-mediated cyp1a1 overexpression during zebrafish heart development

PM2.5 induces cardiac malformations via PI3K/akt2/mTORC1 signaling pathway in zebrafish larvae.

Resveratrol Protects Against PM2.5-induced Heart Defects in Zebrafish Embryos As an Antioxidant Rather Than As an AHR Antagonist

Exposure to Acrylamide Induces Cardiac Developmental Toxicity in Zebrafish During Cardiogenesis

Exposure to Volatile Organic Compounds Induces Cardiovascular Toxicity That May Involve DNA Methylation

Developmental Toxicity Induced by PM2.5 Through Endoplasmic Reticulum Stress and Autophagy Pathway in Zebrafish Embryos

Impact of DNA methyltransferase inhibitor 5‐azacytidine on cardiac development of zebrafish in vivo and cardiomyocyte proliferation, apoptosis, and the homeostasis of gene expression in vitro

Characterization of Acrylamide-Induced Oxidative Stress and Cardiovascular Toxicity in Zebrafish Embryos.

Real-ambient particulate matter exposure-induced FGFR1 methylation contributes to cardiac dysfunction via lipid metabolism disruption

Folic acid supplement rescues ethanol-induced developmental defects in the zebrafish embryos

Developmental toxicity and metabolomics analyses of zebrafish (Danio rerio) embryos exposed to Fenoxaprop-p-ethyl